Literature DB >> 15452696

[Stents in the treatment of intracranial atherosclerotic stenoses].

R du Mesnil de Rochemont1, M Sitzer, F E Zanella, J Berkefeld.   

Abstract

The treatment of intracranial atherosclerotic stenoses, which account for 10-15% of all ischemic strokes, is technically feasible for few years by the use of new flexible stent devices. Especially patients who fail best medical treatment have a poor prognosis and stenting becomes a reasonable treatment option. Herein we discuss treatment concepts and the principles of stent placement against the background of epidemiology and pathophysiologic basics.

Entities:  

Mesh：

Year:  2004        PMID： 15452696     DOI： 10.1007/s00117-004-1107-8

Source DB:  PubMed          Journal:  Radiologe        ISSN： 0033-832X            Impact factor:   0.635


  31 in total

1.  Assessment of the trackability, flexibility, and conformability of coronary stents: a comparative analysis.

Authors:  Régis Rieu; Paul Barragan; Vincent Garitey; Pierre O Roquebert; Jean Fuseri; Philippe Commeau; Joel Sainsous
Journal:  Catheter Cardiovasc Interv       Date:  2003-08       Impact factor: 2.692

2.  Fatal cerebral reperfusion hemorrhage after carotid stenting.

Authors:  D J McCabe; M M Brown; A Clifton
Journal:  Stroke       Date:  1999-11       Impact factor: 7.914

3.  Natural history of stenosis from intracranial atherosclerosis by serial angiography.

Authors:  P T Akins; T K Pilgram; D T Cross; C J Moran
Journal:  Stroke       Date:  1998-02       Impact factor: 7.914

4.  Transluminal stent-assisted angiplasty of the intracranial vertebrobasilar system for medically refractory, posterior circulation ischemia: early results.

Authors:  E I Levy; M B Horowitz; C J Koebbe; C C Jungreis; G L Pride; K Dutton; P D Purdy
Journal:  Neurosurgery       Date:  2001-06       Impact factor: 4.654

5.  Short-term arteriographic and clinical outcome after cerebral angioplasty and stenting for intracranial vertebrobasilar and carotid atherosclerotic occlusive disease.

Authors:  T Mori; K Kazita; K Chokyu; T Mima; K Mori
Journal:  AJNR Am J Neuroradiol       Date:  2000-02       Impact factor: 3.825

6.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

7.  Variability of cerebral blood volume and oxygen extraction: stages of cerebral haemodynamic impairment revisited.

Authors:  Colin P Derdeyn; Tom O Videen; Kent D Yundt; Susanne M Fritsch; David A Carpenter; Robert L Grubb; William J Powers
Journal:  Brain       Date:  2002-03       Impact factor: 13.501

8.  Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results.

Authors: 
Journal:  Stroke       Date:  2004-04-22       Impact factor: 7.914

9.  Assessment of >/=50% and <50% intracranial stenoses by transcranial color-coded duplex sonography.

Authors:  R W Baumgartner; H P Mattle; G Schroth
Journal:  Stroke       Date:  1999-01       Impact factor: 7.914

10.  Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study.

Authors:  R L Sacco; D E Kargman; Q Gu; M C Zamanillo
Journal:  Stroke       Date:  1995-01       Impact factor: 7.914
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.